• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国免疫实践专家委员会的结构、角色和程序的专家共识。

Expert Consensus on the Structure, Role, and Procedures of the Korea Expert Committee on Immunization Practices.

机构信息

Allergy and Immunology Center, and Department of Pediatrics, Korea University College of Medicine, Seoul, Korea.

Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea.

出版信息

J Korean Med Sci. 2024 Jun 3;39(21):e166. doi: 10.3346/jkms.2024.39.e166.

DOI:10.3346/jkms.2024.39.e166
PMID:38832476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11147785/
Abstract

BACKGROUND

The Korea Expert Committee on Immunization Practices (KECIP) is a key advisory body the government to develop guidelines and provide technical advisory activities on immunization policies in Korea. A recent policy study, inspired by global best practices, aims to enhance KECIP's functionality for providing timely and transparent recommendations in the face of evolving vaccine science and emerging infectious diseases like COVID-19.

METHODS

This study reviewed the current status of KECIP and collected expert opinions through surveys and consultations. Among the 40 panel members who were surveyed, 19 responded to a questionnaire specifically designed to assess the potential areas of improvement within KECIP.

RESULTS

The majority of respondents favored maintaining the current member count and emphasized the need for a subcommittee. Opinions varied on issues such as the length of KECIP's term, the representation of vaccine manufacturers' perspectives, and the chairperson's role. However, there was a consensus on the importance of expertise, transparency, and fair proceedings within the committee.

CONCLUSION

This study underscores the pivotal role of KECIP in shaping national immunization policies, emphasizing the necessity for informed guidance amidst evolving vaccine science and emerging infectious diseases. Furthermore, it stressed the importance of enhancing KECIP's capacity to effectively address evolving public health challenges and maintain successful immunization programs in South Korea.

摘要

背景

韩国免疫实践专家委员会(KECIP)是政府的一个重要咨询机构,负责制定免疫政策指南并提供技术咨询活动。受全球最佳实践的启发,最近的一项政策研究旨在增强 KECIP 的功能,以便在面对不断发展的疫苗科学和 COVID-19 等新发传染病时,提供及时和透明的建议。

方法

本研究回顾了 KECIP 的现状,并通过调查和咨询收集了专家意见。在接受调查的 40 名小组成员中,有 19 人回答了专门设计的问卷,以评估 KECIP 潜在的改进领域。

结果

大多数受访者赞成保持目前的成员人数,并强调需要一个小组委员会。对于 KECIP 的任期长短、疫苗制造商观点的代表性以及主席的角色等问题,意见不一。然而,委员会内部的专业知识、透明度和公正程序的重要性得到了一致认可。

结论

这项研究强调了 KECIP 在制定国家免疫政策方面的关键作用,强调了在不断发展的疫苗科学和新发传染病背景下,需要有知情的指导。此外,它还强调了增强 KECIP 有效应对不断变化的公共卫生挑战和维持韩国成功免疫计划的能力的重要性。

相似文献

1
Expert Consensus on the Structure, Role, and Procedures of the Korea Expert Committee on Immunization Practices.韩国免疫实践专家委员会的结构、角色和程序的专家共识。
J Korean Med Sci. 2024 Jun 3;39(21):e166. doi: 10.3346/jkms.2024.39.e166.
2
An overview of the national immunization policy making process: the role of the Korea expert committee on immunization practices.国家免疫政策制定过程概述:韩国免疫实践专家委员会的作用。
Korean J Pediatr. 2012 Jan;55(1):1-5. doi: 10.3345/kjp.2012.55.1.1. Epub 2012 Jan 31.
3
Immunization decision-making in the Republic of Korea: the structure and functioning of the Korea Advisory Committee on Immunization Practices.韩国的免疫决策:韩国免疫实践咨询委员会的结构和运作。
Vaccine. 2010 Apr 19;28 Suppl 1:A91-5. doi: 10.1016/j.vaccine.2010.02.040.
4
Developing COVID-19 vaccine recommendations during the pandemic: The experience of Serbia's Expert Committee on Immunization.在大流行期间制定 COVID-19 疫苗接种建议:塞尔维亚免疫专家委员会的经验。
Front Public Health. 2022 Nov 17;10:1056670. doi: 10.3389/fpubh.2022.1056670. eCollection 2022.
5
Canada's National Advisory Committee on immunization: Adaptations and challenges during the COVID-19 pandemic.加拿大免疫咨询委员会:COVID-19 大流行期间的调整与挑战。
Vaccine. 2023 Oct 20;41(44):6538-6547. doi: 10.1016/j.vaccine.2023.08.048. Epub 2023 Aug 30.
6
The National Immunization Technical Advisory Group in Israel.以色列国家免疫技术咨询小组。
Isr J Health Policy Res. 2021 Jan 26;10(1):7. doi: 10.1186/s13584-021-00442-4.
7
The role of National Immunization Technical Advisory Groups in advising COVID-19 immunization policy during the pandemic: lessons from the Federation of Bosnia and Herzegovina.国家免疫技术咨询小组在大流行期间为 COVID-19 免疫政策提供建议的作用:来自波斯尼亚和黑塞哥维那联邦的经验教训。
Front Public Health. 2023 Jun 30;11:1193281. doi: 10.3389/fpubh.2023.1193281. eCollection 2023.
8
The role of National Immunization Technical Advisory Groups (NITAG) in strengthening health system governance: Lessons from three middle-income countries-Argentina, Jordan, and South Africa (2017-2018).国家免疫技术咨询小组(NITAG)在加强卫生系统治理中的作用:来自阿根廷、约旦和南非三个中等收入国家的经验教训(2017-2018 年)。
Vaccine. 2020 Oct 21;38(45):7118-7128. doi: 10.1016/j.vaccine.2020.08.069. Epub 2020 Sep 16.
9
COVID-19 vaccine policy development in a sample of 44 countries - Key findings from a December 2021 survey of National Immunization Technical Advisory Groups (NITAGs).44 个国家的 COVID-19 疫苗政策制定 - 2021 年 12 月对国家免疫技术咨询小组(NITAGs)的调查的主要结果。
Vaccine. 2023 Jan 16;41(3):676-683. doi: 10.1016/j.vaccine.2022.11.029. Epub 2022 Nov 17.
10
Strengthening vaccination policies in Latin America: an evidence-based approach.加强拉丁美洲的疫苗接种政策:循证方法。
Vaccine. 2013 Aug 20;31(37):3826-33. doi: 10.1016/j.vaccine.2012.12.062. Epub 2013 Jan 25.

本文引用的文献

1
COVID-19 vaccine policy development in a sample of 44 countries - Key findings from a December 2021 survey of National Immunization Technical Advisory Groups (NITAGs).44 个国家的 COVID-19 疫苗政策制定 - 2021 年 12 月对国家免疫技术咨询小组(NITAGs)的调查的主要结果。
Vaccine. 2023 Jan 16;41(3):676-683. doi: 10.1016/j.vaccine.2022.11.029. Epub 2022 Nov 17.
2
Appraising the cost-effectiveness of vaccines in the UK: Insights from the Department of Health Consultation on the revision of methods guidelines.评估英国疫苗的成本效益:来自卫生部关于修订方法指南的咨询的见解。
Vaccine. 2019 May 9;37(21):2831-2837. doi: 10.1016/j.vaccine.2019.03.072. Epub 2019 Apr 15.
3
The history of the United States Advisory Committee on Immunization Practices (ACIP).美国免疫实践咨询委员会(ACIP)的历史。
Vaccine. 2015 Jan 9;33(3):405-14. doi: 10.1016/j.vaccine.2014.09.043. Epub 2014 Oct 25.
4
An overview of the national immunization policy making process: the role of the Korea expert committee on immunization practices.国家免疫政策制定过程概述:韩国免疫实践专家委员会的作用。
Korean J Pediatr. 2012 Jan;55(1):1-5. doi: 10.3345/kjp.2012.55.1.1. Epub 2012 Jan 31.
5
Immunization decision-making in the Republic of Korea: the structure and functioning of the Korea Advisory Committee on Immunization Practices.韩国的免疫决策:韩国免疫实践咨询委员会的结构和运作。
Vaccine. 2010 Apr 19;28 Suppl 1:A91-5. doi: 10.1016/j.vaccine.2010.02.040.
6
The Australian model of immunization advice and vaccine funding.澳大利亚的免疫建议和疫苗资金模式。
Vaccine. 2010 Apr 19;28 Suppl 1:A76-83. doi: 10.1016/j.vaccine.2010.02.038.
7
National Immunization Technical Advisory Groups (NITAGs): guidance for their establishment and strengthening.国家免疫技术咨询专家组(NITAGs):建立和加强其指导原则。
Vaccine. 2010 Apr 19;28 Suppl 1:A18-25. doi: 10.1016/j.vaccine.2010.02.027.